Penumbra, Inc Payments to Acquire Debt Securities, Available-for-sale
Penumbra, Inc (PEN) reported Payments to Acquire Debt Securities, Available-for-sale of $357.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-07-30
- Penumbra, Inc payments to acquire debt securities, available-for-sale for the quarter ending 2026-06-30 was $216.19M, a 21619400.00% increase year-over-year.
- Penumbra, Inc payments to acquire debt securities, available-for-sale for the quarter ending 2026-03-31 was $141.10M, a 403045.71% increase year-over-year.
- Penumbra, Inc payments to acquire debt securities, available-for-sale for the quarter ending 2025-12-31 was $209.09M, a 2015.43% increase year-over-year.
- Penumbra, Inc payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-30 was $146.61M, a 8433.88% increase year-over-year.
- Penumbra, Inc payments to acquire debt securities, available-for-sale for fiscal 2025 was $355.74M, a 1452.76% increase from fiscal 2024.
- Penumbra, Inc payments to acquire debt securities, available-for-sale for fiscal 2024 was $22.91M, a 72.04% decline from fiscal 2023.
- Penumbra, Inc payments to acquire debt securities, available-for-sale for fiscal 2023 was $81.94M.
- Penumbra, Inc payments to acquire debt securities, available-for-sale for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $216.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $357.30M 10-Q · filed 2026-07-30 | $566.38M derived: sum of 3 quarters · filed 2026-07-30 | $713.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $141.10M 10-Q · filed 2026-05-06 | $350.19M derived: sum of 2 quarters · filed 2026-05-06 | $496.80M derived: sum of 3 quarters · filed 2026-05-06 | $496.80M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $209.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $355.70M derived: sum of 2 quarters · filed 2026-02-25 | $355.70M derived: sum of 3 quarters · filed 2026-07-30 | $355.74M 10-K · filed 2026-02-25 |
| 2025-09-30 | $146.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $146.61M derived: sum of 2 quarters · filed 2026-07-30 | $146.65M 10-Q · filed 2025-11-05 | $156.53M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $36.00K 10-Q · filed 2026-07-30 | $9.92M derived: sum of 3 quarters · filed 2026-07-30 | $11.64M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $35.00K 10-Q · filed 2026-05-06 | $9.92M derived: sum of 2 quarters · filed 2026-05-06 | $11.64M derived: sum of 3 quarters · filed 2026-05-06 | $11.68M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $9.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $11.60M derived: sum of 2 quarters · filed 2026-02-25 | $11.64M derived: sum of 3 quarters · filed 2026-02-25 | $22.91M 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.76M derived: sum of 2 quarters · filed 2025-11-05 | $13.03M 10-Q · filed 2025-11-05 | $21.60M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $11.31M 10-Q · filed 2025-07-29 | $19.88M derived: sum of 3 quarters · filed 2026-02-25 | $78.05M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $11.27M 10-Q · filed 2025-04-23 | $19.84M derived: sum of 2 quarters · filed 2026-02-25 | $78.01M derived: sum of 3 quarters · filed 2026-02-25 | $93.21M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $8.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $66.75M derived: sum of 2 quarters · filed 2026-02-25 | $81.94M derived: sum of 3 quarters · filed 2026-02-25 | $81.94M 10-K · filed 2026-02-25 |
| 2023-09-30 | $58.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $73.37M derived: sum of 2 quarters · filed 2024-10-30 | $73.37M 10-Q · filed 2024-10-30 | $73.37M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $15.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $15.19M 10-Q · filed 2024-07-30 | $15.19M derived: sum of 3 quarters · filed 2025-02-18 | $15.19M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | $0.00 derived: sum of 3 quarters · filed 2025-02-18 | $0.00 derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | $0.00 derived: sum of 3 quarters · filed 2025-02-18 | $0.00 10-K · filed 2025-02-18 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | $19.67M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $0.00 10-Q · filed 2023-08-01 | $19.67M derived: sum of 3 quarters · filed 2024-02-22 | $93.86M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-03 | $19.67M derived: sum of 2 quarters · filed 2024-02-22 | $93.86M derived: sum of 3 quarters · filed 2024-02-22 | $114.53M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $19.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $93.86M derived: sum of 2 quarters · filed 2024-02-22 | $114.53M derived: sum of 3 quarters · filed 2024-02-22 | $126.79M 10-K · filed 2024-02-22 |
| 2021-09-30 | $74.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $94.86M derived: sum of 2 quarters · filed 2022-11-03 | $107.13M 10-Q · filed 2022-11-03 | $140.17M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $20.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $32.94M 10-Q · filed 2022-08-05 | $65.99M derived: sum of 3 quarters · filed 2023-02-23 | |
| 2021-03-31 | $12.27M 10-Q · filed 2022-05-03 | $45.31M derived: sum of 2 quarters · filed 2023-02-23 | ||
| 2020-12-31 | $33.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $153.06M 10-K · filed 2023-02-23 | ||
| 2020-09-30 | $120.01M 10-Q · filed 2021-11-03 | |||
| 2019-12-31 | $77.33M 10-K · filed 2022-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |